ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Bio Similars & Subsequent Entry Biologic Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-16A5970
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Bio Similars Subsequent Entry Biologic Market Insights and Forecast to 2028
BUY CHAPTERS

Global Bio Similars & Subsequent Entry Biologic Market Research Report 2025

Code: QYRE-Auto-16A5970
Report
September 2025
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen Idec
Genentech (Roche)
Pfizer Inc
Celltrion
Biocon Ltd.
Amgen Inc
Samsung Biologics
Mylan NV
Dr. Reddy’s Laboratories
STADA Arzneimittel AG
AbbVie
Sanofi Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3SBio Inc
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Johnson & Johnson

Bio Similars & Subsequent Entry Biologic Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bio Similars & Subsequent Entry Biologic Market

Bio Similars & Subsequent Entry Biologic Market

The global market for Bio Similars & Subsequent Entry Biologic was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Bio Similars, also known as Subsequent Entry Biologics (SEBs), are biological products that are highly similar to an already approved biological reference product. They are designed to have comparable quality, safety, and efficacy to the reference product, and are approved based on demonstrating similarity in terms of structure, function, pharmacokinetics, pharmacodynamics, immunogenicity, and clinical outcomes. Bio Similars are different from generic drugs, which are identical copies of small-molecule drugs that can be easily synthesized.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Bio Similars & Subsequent Entry Biologic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bio Similars & Subsequent Entry Biologic.
The Bio Similars & Subsequent Entry Biologic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bio Similars & Subsequent Entry Biologic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bio Similars & Subsequent Entry Biologic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Bio Similars & Subsequent Entry Biologic Market Report

Report Metric Details
Report Name Bio Similars & Subsequent Entry Biologic Market
CAGR 5%
Segment by Type
  • Monoclonal Antibodies
  • Interferon
  • Erythropoietin
  • Insulin
  • Vaccines
  • Others
Segment by Application
  • Tumor
  • Diabetes
  • Cardiovascular
  • Hemophilia
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy's Laboratories, Stada Arzneimittel AG, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Bio Similars & Subsequent Entry Biologic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bio Similars & Subsequent Entry Biologic Market report?

Ans: The main players in the Bio Similars & Subsequent Entry Biologic Market are Sun Pharma, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion Biocon, Hospira, Merck, Biogen idec, Genentech (Roche), Pfizer, Celltrion, Biocon, Amgen, Samsung Biologics, Mylan, Dr. Reddy's Laboratories, Stada Arzneimittel AG, AbbVie, Sanofi-Aventis, Johnson & Johnson, Novo Nordisk, Eli Lilly, Novartis, 3sbio, Biotech, Gelgen, Innovent, Dong Bao, Ganlee

What are the Application segmentation covered in the Bio Similars & Subsequent Entry Biologic Market report?

Ans: The Applications covered in the Bio Similars & Subsequent Entry Biologic Market report are Tumor, Diabetes, Cardiovascular, Hemophilia, Others

What are the Type segmentation covered in the Bio Similars & Subsequent Entry Biologic Market report?

Ans: The Types covered in the Bio Similars & Subsequent Entry Biologic Market report are Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Others
1.3 Market by Application
1.3.1 Global Bio Similars & Subsequent Entry Biologic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bio Similars & Subsequent Entry Biologic Market Perspective (2020-2031)
2.2 Global Bio Similars & Subsequent Entry Biologic Growth Trends by Region
2.2.1 Global Bio Similars & Subsequent Entry Biologic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Bio Similars & Subsequent Entry Biologic Historic Market Size by Region (2020-2025)
2.2.3 Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Region (2026-2031)
2.3 Bio Similars & Subsequent Entry Biologic Market Dynamics
2.3.1 Bio Similars & Subsequent Entry Biologic Industry Trends
2.3.2 Bio Similars & Subsequent Entry Biologic Market Drivers
2.3.3 Bio Similars & Subsequent Entry Biologic Market Challenges
2.3.4 Bio Similars & Subsequent Entry Biologic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bio Similars & Subsequent Entry Biologic Players by Revenue
3.1.1 Global Top Bio Similars & Subsequent Entry Biologic Players by Revenue (2020-2025)
3.1.2 Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Players (2020-2025)
3.2 Global Bio Similars & Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Bio Similars & Subsequent Entry Biologic Revenue
3.4 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio
3.4.1 Global Bio Similars & Subsequent Entry Biologic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bio Similars & Subsequent Entry Biologic Revenue in 2024
3.5 Global Key Players of Bio Similars & Subsequent Entry Biologic Head office and Area Served
3.6 Global Key Players of Bio Similars & Subsequent Entry Biologic, Product and Application
3.7 Global Key Players of Bio Similars & Subsequent Entry Biologic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Bio Similars & Subsequent Entry Biologic Breakdown Data by Type
4.1 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Type (2020-2025)
4.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2026-2031)
5 Bio Similars & Subsequent Entry Biologic Breakdown Data by Application
5.1 Global Bio Similars & Subsequent Entry Biologic Historic Market Size by Application (2020-2025)
5.2 Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
6.2 North America Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
6.4 North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
7.2 Europe Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
7.4 Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
8.2 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025)
8.4 Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
9.2 Latin America Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
9.4 Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size (2020-2031)
10.2 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025)
10.4 Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sun Pharma
11.1.1 Sun Pharma Company Details
11.1.2 Sun Pharma Business Overview
11.1.3 Sun Pharma Bio Similars & Subsequent Entry Biologic Introduction
11.1.4 Sun Pharma Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.1.5 Sun Pharma Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Bio Similars & Subsequent Entry Biologic Introduction
11.4.4 LG Life Sciences Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Bio Similars & Subsequent Entry Biologic Introduction
11.5.4 Celltrion Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Bio Similars & Subsequent Entry Biologic Introduction
11.6.4 Hospira Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.6.5 Hospira Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Bio Similars & Subsequent Entry Biologic Introduction
11.7.4 Merck Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.7.5 Merck Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Bio Similars & Subsequent Entry Biologic Introduction
11.8.4 Biogen idec Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Bio Similars & Subsequent Entry Biologic Introduction
11.9.4 Genentech (Roche) Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.9.5 Genentech (Roche) Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Bio Similars & Subsequent Entry Biologic Introduction
11.10.4 Pfizer Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.10.5 Pfizer Recent Development
11.11 Celltrion
11.11.1 Celltrion Company Details
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Bio Similars & Subsequent Entry Biologic Introduction
11.11.4 Celltrion Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.11.5 Celltrion Recent Development
11.12 Biocon
11.12.1 Biocon Company Details
11.12.2 Biocon Business Overview
11.12.3 Biocon Bio Similars & Subsequent Entry Biologic Introduction
11.12.4 Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.12.5 Biocon Recent Development
11.13 Amgen
11.13.1 Amgen Company Details
11.13.2 Amgen Business Overview
11.13.3 Amgen Bio Similars & Subsequent Entry Biologic Introduction
11.13.4 Amgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.13.5 Amgen Recent Development
11.14 Samsung Biologics
11.14.1 Samsung Biologics Company Details
11.14.2 Samsung Biologics Business Overview
11.14.3 Samsung Biologics Bio Similars & Subsequent Entry Biologic Introduction
11.14.4 Samsung Biologics Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.14.5 Samsung Biologics Recent Development
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Bio Similars & Subsequent Entry Biologic Introduction
11.15.4 Mylan Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.15.5 Mylan Recent Development
11.16 Dr. Reddy's Laboratories
11.16.1 Dr. Reddy's Laboratories Company Details
11.16.2 Dr. Reddy's Laboratories Business Overview
11.16.3 Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Introduction
11.16.4 Dr. Reddy's Laboratories Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.16.5 Dr. Reddy's Laboratories Recent Development
11.17 Stada Arzneimittel AG
11.17.1 Stada Arzneimittel AG Company Details
11.17.2 Stada Arzneimittel AG Business Overview
11.17.3 Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Introduction
11.17.4 Stada Arzneimittel AG Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.17.5 Stada Arzneimittel AG Recent Development
11.18 AbbVie
11.18.1 AbbVie Company Details
11.18.2 AbbVie Business Overview
11.18.3 AbbVie Bio Similars & Subsequent Entry Biologic Introduction
11.18.4 AbbVie Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.18.5 AbbVie Recent Development
11.19 Sanofi-Aventis
11.19.1 Sanofi-Aventis Company Details
11.19.2 Sanofi-Aventis Business Overview
11.19.3 Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Introduction
11.19.4 Sanofi-Aventis Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.19.5 Sanofi-Aventis Recent Development
11.20 Johnson & Johnson
11.20.1 Johnson & Johnson Company Details
11.20.2 Johnson & Johnson Business Overview
11.20.3 Johnson & Johnson Bio Similars & Subsequent Entry Biologic Introduction
11.20.4 Johnson & Johnson Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.20.5 Johnson & Johnson Recent Development
11.21 Novo Nordisk
11.21.1 Novo Nordisk Company Details
11.21.2 Novo Nordisk Business Overview
11.21.3 Novo Nordisk Bio Similars & Subsequent Entry Biologic Introduction
11.21.4 Novo Nordisk Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.21.5 Novo Nordisk Recent Development
11.22 Eli Lilly
11.22.1 Eli Lilly Company Details
11.22.2 Eli Lilly Business Overview
11.22.3 Eli Lilly Bio Similars & Subsequent Entry Biologic Introduction
11.22.4 Eli Lilly Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.22.5 Eli Lilly Recent Development
11.23 Novartis
11.23.1 Novartis Company Details
11.23.2 Novartis Business Overview
11.23.3 Novartis Bio Similars & Subsequent Entry Biologic Introduction
11.23.4 Novartis Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.23.5 Novartis Recent Development
11.24 3sbio
11.24.1 3sbio Company Details
11.24.2 3sbio Business Overview
11.24.3 3sbio Bio Similars & Subsequent Entry Biologic Introduction
11.24.4 3sbio Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.24.5 3sbio Recent Development
11.25 Biotech
11.25.1 Biotech Company Details
11.25.2 Biotech Business Overview
11.25.3 Biotech Bio Similars & Subsequent Entry Biologic Introduction
11.25.4 Biotech Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.25.5 Biotech Recent Development
11.26 Gelgen
11.26.1 Gelgen Company Details
11.26.2 Gelgen Business Overview
11.26.3 Gelgen Bio Similars & Subsequent Entry Biologic Introduction
11.26.4 Gelgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.26.5 Gelgen Recent Development
11.27 Innovent
11.27.1 Innovent Company Details
11.27.2 Innovent Business Overview
11.27.3 Innovent Bio Similars & Subsequent Entry Biologic Introduction
11.27.4 Innovent Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.27.5 Innovent Recent Development
11.28 Dong Bao
11.28.1 Dong Bao Company Details
11.28.2 Dong Bao Business Overview
11.28.3 Dong Bao Bio Similars & Subsequent Entry Biologic Introduction
11.28.4 Dong Bao Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.28.5 Dong Bao Recent Development
11.29 Ganlee
11.29.1 Ganlee Company Details
11.29.2 Ganlee Business Overview
11.29.3 Ganlee Bio Similars & Subsequent Entry Biologic Introduction
11.29.4 Ganlee Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
11.29.5 Ganlee Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sun Pharma
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck
Biogen Idec
Genentech (Roche)
Pfizer Inc
Celltrion
Biocon Ltd.
Amgen Inc
Samsung Biologics
Mylan NV
Dr. Reddy’s Laboratories
STADA Arzneimittel AG
AbbVie
Sanofi Aventis
Johnson & Johnson
Novo Nordisk
Eli Lilly
Novartis
3SBio Inc
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Johnson & Johnson
List of Tables
 Table 1. Global Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Interferon
 Table 4. Key Players of Erythropoietin
 Table 5. Key Players of Insulin
 Table 6. Key Players of Vaccines
 Table 7. Key Players of Others
 Table 8. Global Bio Similars & Subsequent Entry Biologic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Bio Similars & Subsequent Entry Biologic Market Share by Region (2020-2025)
 Table 12. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Bio Similars & Subsequent Entry Biologic Market Share by Region (2026-2031)
 Table 14. Bio Similars & Subsequent Entry Biologic Market Trends
 Table 15. Bio Similars & Subsequent Entry Biologic Market Drivers
 Table 16. Bio Similars & Subsequent Entry Biologic Market Challenges
 Table 17. Bio Similars & Subsequent Entry Biologic Market Restraints
 Table 18. Global Bio Similars & Subsequent Entry Biologic Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Bio Similars & Subsequent Entry Biologic Market Share by Players (2020-2025)
 Table 20. Global Top Bio Similars & Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2024)
 Table 21. Ranking of Global Top Bio Similars & Subsequent Entry Biologic Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Bio Similars & Subsequent Entry Biologic Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Bio Similars & Subsequent Entry Biologic, Headquarters and Area Served
 Table 24. Global Key Players of Bio Similars & Subsequent Entry Biologic, Product and Application
 Table 25. Global Key Players of Bio Similars & Subsequent Entry Biologic, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Bio Similars & Subsequent Entry Biologic Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2020-2025)
 Table 29. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Type (2026-2031)
 Table 31. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2020-2025)
 Table 33. Global Bio Similars & Subsequent Entry Biologic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Bio Similars & Subsequent Entry Biologic Revenue Market Share by Application (2026-2031)
 Table 35. North America Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Sun Pharma Company Details
 Table 51. Sun Pharma Business Overview
 Table 52. Sun Pharma Bio Similars & Subsequent Entry Biologic Product
 Table 53. Sun Pharma Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 54. Sun Pharma Recent Development
 Table 55. Synthon Pharmaceuticals Company Details
 Table 56. Synthon Pharmaceuticals Business Overview
 Table 57. Synthon Pharmaceuticals Bio Similars & Subsequent Entry Biologic Product
 Table 58. Synthon Pharmaceuticals Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 59. Synthon Pharmaceuticals Recent Development
 Table 60. Teva Pharmaceutical Industries Company Details
 Table 61. Teva Pharmaceutical Industries Business Overview
 Table 62. Teva Pharmaceutical Industries Bio Similars & Subsequent Entry Biologic Product
 Table 63. Teva Pharmaceutical Industries Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 64. Teva Pharmaceutical Industries Recent Development
 Table 65. LG Life Sciences Company Details
 Table 66. LG Life Sciences Business Overview
 Table 67. LG Life Sciences Bio Similars & Subsequent Entry Biologic Product
 Table 68. LG Life Sciences Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 69. LG Life Sciences Recent Development
 Table 70. Celltrion Biocon Company Details
 Table 71. Celltrion Biocon Business Overview
 Table 72. Celltrion Biocon Bio Similars & Subsequent Entry Biologic Product
 Table 73. Celltrion Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 74. Celltrion Biocon Recent Development
 Table 75. Hospira Company Details
 Table 76. Hospira Business Overview
 Table 77. Hospira Bio Similars & Subsequent Entry Biologic Product
 Table 78. Hospira Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 79. Hospira Recent Development
 Table 80. Merck Company Details
 Table 81. Merck Business Overview
 Table 82. Merck Bio Similars & Subsequent Entry Biologic Product
 Table 83. Merck Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 84. Merck Recent Development
 Table 85. Biogen idec Company Details
 Table 86. Biogen idec Business Overview
 Table 87. Biogen idec Bio Similars & Subsequent Entry Biologic Product
 Table 88. Biogen idec Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 89. Biogen idec Recent Development
 Table 90. Genentech (Roche) Company Details
 Table 91. Genentech (Roche) Business Overview
 Table 92. Genentech (Roche) Bio Similars & Subsequent Entry Biologic Product
 Table 93. Genentech (Roche) Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 94. Genentech (Roche) Recent Development
 Table 95. Pfizer Company Details
 Table 96. Pfizer Business Overview
 Table 97. Pfizer Bio Similars & Subsequent Entry Biologic Product
 Table 98. Pfizer Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 99. Pfizer Recent Development
 Table 100. Celltrion Company Details
 Table 101. Celltrion Business Overview
 Table 102. Celltrion Bio Similars & Subsequent Entry Biologic Product
 Table 103. Celltrion Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 104. Celltrion Recent Development
 Table 105. Biocon Company Details
 Table 106. Biocon Business Overview
 Table 107. Biocon Bio Similars & Subsequent Entry Biologic Product
 Table 108. Biocon Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 109. Biocon Recent Development
 Table 110. Amgen Company Details
 Table 111. Amgen Business Overview
 Table 112. Amgen Bio Similars & Subsequent Entry Biologic Product
 Table 113. Amgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 114. Amgen Recent Development
 Table 115. Samsung Biologics Company Details
 Table 116. Samsung Biologics Business Overview
 Table 117. Samsung Biologics Bio Similars & Subsequent Entry Biologic Product
 Table 118. Samsung Biologics Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 119. Samsung Biologics Recent Development
 Table 120. Mylan Company Details
 Table 121. Mylan Business Overview
 Table 122. Mylan Bio Similars & Subsequent Entry Biologic Product
 Table 123. Mylan Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 124. Mylan Recent Development
 Table 125. Dr. Reddy's Laboratories Company Details
 Table 126. Dr. Reddy's Laboratories Business Overview
 Table 127. Dr. Reddy's Laboratories Bio Similars & Subsequent Entry Biologic Product
 Table 128. Dr. Reddy's Laboratories Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 129. Dr. Reddy's Laboratories Recent Development
 Table 130. Stada Arzneimittel AG Company Details
 Table 131. Stada Arzneimittel AG Business Overview
 Table 132. Stada Arzneimittel AG Bio Similars & Subsequent Entry Biologic Product
 Table 133. Stada Arzneimittel AG Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 134. Stada Arzneimittel AG Recent Development
 Table 135. AbbVie Company Details
 Table 136. AbbVie Business Overview
 Table 137. AbbVie Bio Similars & Subsequent Entry Biologic Product
 Table 138. AbbVie Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 139. AbbVie Recent Development
 Table 140. Sanofi-Aventis Company Details
 Table 141. Sanofi-Aventis Business Overview
 Table 142. Sanofi-Aventis Bio Similars & Subsequent Entry Biologic Product
 Table 143. Sanofi-Aventis Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 144. Sanofi-Aventis Recent Development
 Table 145. Johnson & Johnson Company Details
 Table 146. Johnson & Johnson Business Overview
 Table 147. Johnson & Johnson Bio Similars & Subsequent Entry Biologic Product
 Table 148. Johnson & Johnson Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 149. Johnson & Johnson Recent Development
 Table 150. Novo Nordisk Company Details
 Table 151. Novo Nordisk Business Overview
 Table 152. Novo Nordisk Bio Similars & Subsequent Entry Biologic Product
 Table 153. Novo Nordisk Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 154. Novo Nordisk Recent Development
 Table 155. Eli Lilly Company Details
 Table 156. Eli Lilly Business Overview
 Table 157. Eli Lilly Bio Similars & Subsequent Entry Biologic Product
 Table 158. Eli Lilly Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 159. Eli Lilly Recent Development
 Table 160. Novartis Company Details
 Table 161. Novartis Business Overview
 Table 162. Novartis Bio Similars & Subsequent Entry Biologic Product
 Table 163. Novartis Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 164. Novartis Recent Development
 Table 165. 3sbio Company Details
 Table 166. 3sbio Business Overview
 Table 167. 3sbio Bio Similars & Subsequent Entry Biologic Product
 Table 168. 3sbio Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 169. 3sbio Recent Development
 Table 170. Biotech Company Details
 Table 171. Biotech Business Overview
 Table 172. Biotech Bio Similars & Subsequent Entry Biologic Product
 Table 173. Biotech Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 174. Biotech Recent Development
 Table 175. Gelgen Company Details
 Table 176. Gelgen Business Overview
 Table 177. Gelgen Bio Similars & Subsequent Entry Biologic Product
 Table 178. Gelgen Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 179. Gelgen Recent Development
 Table 180. Innovent Company Details
 Table 181. Innovent Business Overview
 Table 182. Innovent Bio Similars & Subsequent Entry Biologic Product
 Table 183. Innovent Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 184. Innovent Recent Development
 Table 185. Dong Bao Company Details
 Table 186. Dong Bao Business Overview
 Table 187. Dong Bao Bio Similars & Subsequent Entry Biologic Product
 Table 188. Dong Bao Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 189. Dong Bao Recent Development
 Table 190. Ganlee Company Details
 Table 191. Ganlee Business Overview
 Table 192. Ganlee Bio Similars & Subsequent Entry Biologic Product
 Table 193. Ganlee Revenue in Bio Similars & Subsequent Entry Biologic Business (2020-2025) & (US$ Million)
 Table 194. Ganlee Recent Development
 Table 195. Research Programs/Design for This Report
 Table 196. Key Data Information from Secondary Sources
 Table 197. Key Data Information from Primary Sources
 Table 198. Authors List of This Report


List of Figures
 Figure 1. Bio Similars & Subsequent Entry Biologic Picture
 Figure 2. Global Bio Similars & Subsequent Entry Biologic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Bio Similars & Subsequent Entry Biologic Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Interferon Features
 Figure 6. Erythropoietin Features
 Figure 7. Insulin Features
 Figure 8. Vaccines Features
 Figure 9. Others Features
 Figure 10. Global Bio Similars & Subsequent Entry Biologic Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Bio Similars & Subsequent Entry Biologic Market Share by Application: 2024 VS 2031
 Figure 12. Tumor Case Studies
 Figure 13. Diabetes Case Studies
 Figure 14. Cardiovascular Case Studies
 Figure 15. Hemophilia Case Studies
 Figure 16. Others Case Studies
 Figure 17. Bio Similars & Subsequent Entry Biologic Report Years Considered
 Figure 18. Global Bio Similars & Subsequent Entry Biologic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Bio Similars & Subsequent Entry Biologic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Bio Similars & Subsequent Entry Biologic Market Share by Region: 2024 VS 2031
 Figure 21. Global Bio Similars & Subsequent Entry Biologic Market Share by Players in 2024
 Figure 22. Global Top Bio Similars & Subsequent Entry Biologic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bio Similars & Subsequent Entry Biologic as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Bio Similars & Subsequent Entry Biologic Revenue in 2024
 Figure 24. North America Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Bio Similars & Subsequent Entry Biologic Market Share by Country (2020-2031)
 Figure 26. United States Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Bio Similars & Subsequent Entry Biologic Market Share by Country (2020-2031)
 Figure 30. Germany Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Bio Similars & Subsequent Entry Biologic Market Share by Region (2020-2031)
 Figure 38. China Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Bio Similars & Subsequent Entry Biologic Market Share by Country (2020-2031)
 Figure 46. Mexico Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Bio Similars & Subsequent Entry Biologic Market Share by Country (2020-2031)
 Figure 50. Turkey Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Bio Similars & Subsequent Entry Biologic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Sun Pharma Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 54. Synthon Pharmaceuticals Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 56. LG Life Sciences Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 57. Celltrion Biocon Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 58. Hospira Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 59. Merck Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 60. Biogen idec Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 61. Genentech (Roche) Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 62. Pfizer Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 63. Celltrion Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 64. Biocon Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 65. Amgen Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 66. Samsung Biologics Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 67. Mylan Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 68. Dr. Reddy's Laboratories Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 69. Stada Arzneimittel AG Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 70. AbbVie Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 71. Sanofi-Aventis Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 72. Johnson & Johnson Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 73. Novo Nordisk Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 74. Eli Lilly Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 75. Novartis Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 76. 3sbio Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 77. Biotech Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 78. Gelgen Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 79. Innovent Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 80. Dong Bao Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 81. Ganlee Revenue Growth Rate in Bio Similars & Subsequent Entry Biologic Business (2020-2025)
 Figure 82. Bottom-up and Top-down Approaches for This Report
 Figure 83. Data Triangulation
 Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Biosimilars Follow on Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Living Biological Drugs Market Research Report 2025
Live Biotherapeutic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global TNF IL Cytokines Market Insights Forecast to 2030
Global Diagnostic Guidewire Market Research Report 2024
Global BioPharma Service Market Research Report 2024
Pharmaceutical Retail Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Bulk Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Biologics Drugs Market Research Report 2025
Global Still s Disease Treatment Market Research Report 2025
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specialty Generics Market
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
Tissue Based Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Marine Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ant Killer Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions